4.6 Article

Inside-out: Antibody-binding reveals potential folding hinge-points within the SARS-CoV-2 replication co-factor nsp9

Related references

Note: Only part of the references are listed.
Review Cell Biology

Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design

Brandon Malone et al.

Summary: The molecular basis and complexity of coronavirus RNA-synthesizing machinery is still not fully understood. Recent research has focused on deciphering and understanding the structures, functions, and interactions of the subunits involved in SARS-CoV-2 replication and transcription. Both viral and host factors play a crucial role in coordinating RNA translation, replication, and transcription, making them potential targets for antiviral therapy.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

Rana Abdelnabi et al.

Summary: There is an urgent need for potent and selective antivirals against SARS-CoV-2. Pfizer has developed PF-07321332 (PF-332), a powerful inhibitor of the viral main protease (Mpro, 3CLpro), which can be taken orally and is currently in clinical development. In this study, it was found that PF-332 has equal in vitro activity against the four SARS-CoV-2 variants of concern and can completely halt replication of the alpha variant in human airway epithelial cells. The treatment with PF-332 protected Syrian Golden hamsters against infection with the beta and delta variants and prevented transmission of the SARS-CoV-2 (B.1.617.2) variant to untreated co-housed sentinels.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2

Serene El-Kamand et al.

Summary: SARS-CoV-2, a novel and highly infectious RNA virus, relies on the Nsp9 protein for RNA binding during replication. Recent studies using NMR and BLI techniques have revealed a distinct binding interface between Nsp9 and RNA, providing insights into the molecular details of these interactions. This sheds light on the structural characteristics of the Nsp9-RNA complex within the coronavirus family.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2022)

Article Biophysics

Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - μs) dynamics in the C-terminal helix at the dimer interface

Garry W. Buchko et al.

Summary: This study investigates the dynamics of the SARS-CoV-2 Nsp9 protein in solution and its potential ligand-binding surfaces through chemical shift perturbation studies. By extensively assigning NMR chemical shifts, the research reveals missing amide resonances in the C-terminal region of the protein, suggesting intermediate motion or heterogeneity in this area.

BIOMOLECULAR NMR ASSIGNMENTS (2021)

Article Biochemistry & Molecular Biology

Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis

Liming Yan et al.

Summary: The study presents a structural snapshot of SARS-CoV-2 RTC during mRNA transcription, revealing the interaction between nsp9 and nsp12, as well as the catalytic activity of nsp12 NiRAN. The results demonstrate an intermediate state of RTC towards mRNA synthesis, providing valuable information for antiviral drug development.
Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Multidisciplinary Sciences

Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit

Heiko Slanina et al.

Summary: The study reveals that coronavirus nsp12 has NMPylation activity, catalyzing the transfer of NMP to nsp9 and essential for virus replication. It also highlights the importance of the phosphoramidate active site in the NNE tripeptide sequence.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

A natural product compound inhibits coronaviral replication in vitro to the conserved SARS-CoV-2

Dene R. Littler et al.

Summary: The study shows that oridonin reduces the potential of Nsp9 to act as a substrate for Nsp12's NiRAN domain and has broad antiviral activity at higher doses, decreasing viral titers following infection with SARS-CoV-2 or MERS-CoV.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

Review Virology

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2

Qilong Tang et al.

Summary: Nanobodies, derived from heavy-chain-only subclass of Camelid immunogloblins, are small-sized molecules with high affinity and stability, making them unique targeting reagents in biomedical sciences. With the rapid spread of SARS-CoV-2, nanobodies directed against the viral Spike protein have shown promising results in neutralizing the virus, with some agents already undergoing clinical trials. Researchers are studying the structural features guiding nanobody recognition to develop effective treatments against the pandemic.

VIRUSES-BASEL (2021)

Article Microbiology

Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model

Kei Haga et al.

Summary: The study shows that K-874A effectively inhibits SARS-CoV-2 and reduces virus replication by blocking viral membrane fusion instead of viral attachment. This antibody could be a potential new treatment for preventing reinfection of the virus in COVID-19 patients.

PLOS PATHOGENS (2021)

Article Materials Science, Biomaterials

NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19

Gennaro Esposito et al.

Summary: A study generated 136 unique nanobodies targeting Nsp9, which effectively recognize and stabilize its tetrameric form. These results have important implications for using these nanobodies to combat viral replication.

ADVANCED BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Coupling of N7-methyltransferase and 3′-5′ exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading

Liming Yan et al.

Summary: The study presents the cryo-EM structure of the SARS-CoV-2 replication-transcription complex (RTC) Cap(0)-RTC, demonstrating the proofreading mechanism of nsp14 and the role of nsp10/nsp14 in the formation of the capping complex.
Article Infectious Diseases

Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies

Thomas Guettler et al.

Summary: This study introduces the use of single-domain (VHH) antibodies as an alternative for combating SARS-CoV-2, showing their ability to neutralize the virus, inhibit its infectivity, and tolerate immune-escape mutations. The research also suggests that this approach may simplify vaccine production and adapt to viral escape mutations.

LANCET INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9

Dene R. Littler et al.

Summary: A pyrrolo-pyrimidine compound identified from a fragment screen interacts with Nsp9 via tetrameric Pi-Pi stacking, inducing the formation of a trimer-of-dimers. This compound may serve as a starting point for exploring the role of Nsp9 in SARS-CoV-2 replication.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain

Bing Wang et al.

Summary: The catalytic subunit of SARS-CoV-2 RdRp contains two active sites, one of which is NiRAN, essential for viral replication. Research has shown that NMPylation process can utilize diverse nucleotide triphosphates, as well as being inhibited by nucleotide analogs and bisphosphonates.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies

Thomas Guettler et al.

Summary: Monoclonal anti-SARS-CoV-2 immunoglobulins are effective in treating COVID-19, but their production in mammalian cells is not scalable. This study isolated 45 infection-blocking VHH antibodies from alpaca immune libraries, with one particularly effective VHH antibody capable of neutralizing the virus at low concentrations and showing strong binding to the Spike protein in different conformations. Additionally, the research identified VHH antibodies that can tolerate immune-escape mutations, as well as fold-promoting nanobodies that could simplify vaccine production and adaptation to viral mutations.

EMBO JOURNAL (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

Quan Wang et al.

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9

Dene R. Littler et al.

ISCIENCE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Abhik K. Banerjee et al.

Review Biochemistry & Molecular Biology

An Inside Job: Applications of Intracellular Single Domain Antibodies

Eline Soetens et al.

BIOMOLECULES (2020)

Article Biochemical Research Methods

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

Dorothee Liebschner et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

A series of PDB-related databanks for everyday needs

Wouter G. Touw et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemical Research Methods

In vitro capping and transcription of rhabdoviruses

Tomoaki Ogino

METHODS (2013)

Article Biochemical Research Methods

Overview of the CCP4 suite and current developments

Martyn D. Winn et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemistry & Molecular Biology

Variable Oligomerization Modes in Coronavirus Non-structural Protein 9

Rajesh Ponnusamy et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Article Multidisciplinary Sciences

The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world

MP Egloff et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

The nsp9 replicase protein of SARS-coronavirus, structure and functional insights

G Sutton et al.

STRUCTURE (2004)